Pharmacy, Natural & Health Sciences

MS in Pharmacogenomics Online Program 
Course Sequence - Fall Start

34 Credits

There are two sessions per semester. Each session is half of a total semester length. Students have the option to take one session during a semester or enroll in the full semester, for a total of two sessions. The online program is designed to be flexible to fit around your personal life and professional life! Below is a sample course schedule if a student begins the program in the fall (August) and wants to complete the program in 2 years. To discuss course schedules for a spring (January) start or have specific questions regarding an individualized schedule for the online program please contact the Office of Student and Alumni Experience 260-470-2678 or pgx@manchester.edu.

Please note: The online program must be completed within five academic calendar years of the start date of the program.

 

  • Fall Start (2 Years)

  • Semester

  • Course

  • Course Descriptions

  • Number of Credits

  • Fall A

  • PGX 501 Introduction to Pharmacogenomics

  • Prerequisite: none

    A presentation of the evolution of pharmacogenetics/pharmacogenomics, the human genome and modern applications of DNA information related to drugs. There will also be focused attention to necessary calculations for research and an introduction to pharmacokinetics.

  • 2

  • Fall B

  • PGX 505 Pharmacology

  • Prerequisite: none

    Discusses the cellular and molecular mechanisms of drug action, studied within the disciplines of neuropharmacology and cardiovascular pharmacology, endocrine pharmacology, antimicrobials, and cancer pharmacology. Included are lectures on basic physiology that underlie the mechanisms of important pharmacological agents. Special topics include drug discovery, new uses for established drugs, and pharmacogenetic/pharmacogenomic effects.

  • 4

  • TOTAL NUMBER OF CREDITS - FALL SEMESTER

  • 6

  • Spring A

  • PGX 512 Advanced Pharmacokinetics

  • Prerequisite: PGX 501 (grade of “C” or better or permission)

    Discusses the mathematical and conceptual study of the time course of drug absorption, distribution, metabolism, and excretion.

  • 2

  • Spring A & B

  • PGX 521 Human Genetics (Can be completed in 7-14 weeks)

  • Prerequisite: none

    Discusses how genes influence human traits, diseases, and behaviors, including how non-genetic factors interact with genetic factors to produce observable phenotypes. Human inheritance patterns, genome organization, linkage, and medical applications of genetics in the diagnosis, treatment, and prevention of disease will be explored. There will also be an introduction to molecular biology.

  • 4

  • TOTAL NUMBER OF CREDITS - SPRING SEMESTER

  • 6

  • Summer A

  • PGX 533 Data Analysis/Biostatistics

  • Prerequisite: none

    Discusses the use of statistical methods to process public health and genetic data. An emphasis on interpretation and concepts in areas such as population genetics, genome-wide association studies and systems biology will be undertaken.

  • 3

  • Summer A
  • PGX 515 Research Responsibility and Ethics
  • Prerequisite: none

    Discusses ethics of scientific research involving humans. Bioethics and how it is applied to design and conduct of human drug research. Ethical issues involved with personal genetic information will be emphasized. 

  • Summer B

  • PGX 511 Advanced Molecular Biology

  • Prerequisite: PGX 521 (grade of “C” or better or permission)

    Concepts will be related to analytical methodology. Current approaches to DNA manipulation and mutation analysis, protein assays, quantitative analysis of gene expression, sequencing, immunostaining, microscopy, and image analysis will be discussed.

  • 3

  • TOTAL NUMBER OF CREDITS – SUMMER SEMESTER

  • 7

  • Fall A

  • PGX 531 Bioinformatics

  • Prerequisite: none

    Introduction and exploration of the computational and informational aspects of genomics and proteomics. Includes aspects of sequence similarity analysis, sequence similarity searches, pair-wise analysis, phylogenic trees (and relevance to human genomics), allelic variation analysis, user interface in health care management, population genetics, genomics data results analysis, data quality, and predictions and confirmations of genomics-based altered drug responses.

  • 4

  • Fall B

  • PGX 526 Applied Pharmacogenomics I

  • Prerequisite: PGX 501 (grade of “C” or better or permission)

    Discusses single nucleotide polymorphisms and other genetic variations and their potential impact on clinical medicine and related clinical outcomes. The translation of genetic variations to drug selection, dosing regimens, adverse effects, and regimen optimization will be discussed.

  • 3

  • TOTAL NUMBER OF CREDITS - FALL SEMESTER

  • 7

  • Spring A

  • PGX 536 Applied Pharmacogenomics II

  • Prerequisites: PGX 501 and PGX 526 (grade of “C” or better or permission)

    A continuation of Applied Pharmacogenomics and will continue to focus on single nucleotide polymorphisms and other genetic variation and their potential impact on clinical medicine and related clinical outcomes. The translation of genetic variations to drug selection, dosing regimens, adverse effects, and regimen optimization will be discussed.

  • 3

  • Spring B

  • PGX 5XX Pharmacogenomics in Practice I

  • Prerequisites: PGX 501 (grade of “C” or better or permission)

    A two-part course focused in application of pharmacogenomics in a practice setting. The course will include write-ups and discussions of complicated patient cases. The course will also include the composition of a business plan or implementation plan for introducing pharmacogenomics into the practice of a practicum site.

  • 3

  • TOTAL NUMBER OF CREDITS - SPRING SEMESTER

  • 6

  • Summer A

  • PGX 5XX Pharmacogenomics in Practice II

  • Prerequisites: PGX 501 and PGX 5XX, Pharmacogenomics in Practice I (grade of “C” or better or permission)

    Continuation of Pharmacogenomics in Practice I

  • 2

  • TOTAL NUMBER OF CREDITS - SUMMER SEMESTER

  • 2